Thus, despite activating the adaptive immune system against ovarian cancer growth, most likely through T-cell recruitment, CX3CL1 overexpression promotes intraperitoneal tumour spread and shortens survival, very well reflecting the adverse prognostic impact in human HGSOC as shown before. This evidence concerns the gene CX3CL1 and ovarian cancer.